Gilead Sciences GILD NASDAQ:GILD

Hot Biotech Watch List: InterMune Inc (NASDAQ:ITMN), Merrimack Pharmaceuticals (NASDAQ:MACK), China Biologic Products (NASDAQ:CBPO), VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA)

InterMune, Inc. (NASDAQ:ITMN) on 27 May 2014 announced that it has resubmitted its pirfenidone New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in May 2010. Pirfenidone is being developed for the treatment of adult patients with idiopathic pulmonary fibrosis (IPF). InterMune Inc (NASDAQ:ITMN) stock performance was -0.88% in last session and finished … Continue reading Hot Biotech Watch List: InterMune Inc (NASDAQ:ITMN), Merrimack Pharmaceuticals (NASDAQ:MACK), China Biologic Products (NASDAQ:CBPO), VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA)

Gilead Sciences GILD NASDAQ:GILD

New Highs: China Biologic Products Inc (NASDAQ:CBPO), Centene Corp (NYSE:CNC), LifePoint Hospitals, Inc. (NASDAQ:LPNT), Universal Health Services, Inc. (NYSE:UHS)

Jefferies Group assumed coverage on shares of China Biologic Products (NASDAQ:CBPO) in a report released on Thursday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $52.00 price objective on the stock. China Biologic Products Inc (NASDAQ:CBPO) stock performance was 1.37% in last session and finished the day at $43.67. Traded volume was 59,338.00million shares in the last session and the average volume of … Continue reading New Highs: China Biologic Products Inc (NASDAQ:CBPO), Centene Corp (NYSE:CNC), LifePoint Hospitals, Inc. (NASDAQ:LPNT), Universal Health Services, Inc. (NYSE:UHS)

Unusual Volume at bioetch stocks: CASI Pharmaceuticals (NASDAQ:CASI), Codexis (NASDAQ:CDXS), China Biologic Products (NASDAQ:CBPO), Revance Therapeutics (NASDAQ:RVNC), Oncolytics Biotech, (NASDAQ:ONCY)

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that its orally-active, Aurora A/angiogenic kinase inhibitor, ENMD-2076, has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of hepatocellular carcinoma (HCC). CASI Pharmaceuticals Inc (NASDAQ:CASI) stock performance was -4.79% in last session and finished the day at $1.85. … Continue reading Unusual Volume at bioetch stocks: CASI Pharmaceuticals (NASDAQ:CASI), Codexis (NASDAQ:CDXS), China Biologic Products (NASDAQ:CBPO), Revance Therapeutics (NASDAQ:RVNC), Oncolytics Biotech, (NASDAQ:ONCY)